a US Environmental Protection Agency, Office of Research and Development , National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division , Duluth , MN , USA.
SAR QSAR Environ Res. 2014;25(4):289-323. doi: 10.1080/1062936X.2014.898692.
Regulatory agencies are charged with addressing the endocrine disrupting potential of large numbers of chemicals for which there is often little or no data on which to make decisions. Prioritizing the chemicals of greatest concern for further screening for potential hazard to humans and wildlife is an initial step in the process. This paper presents the collection of in vitro data using assays optimized to detect low affinity estrogen receptor (ER) binding chemicals and the use of that data to build effects-based chemical categories following QSAR approaches and principles pioneered by Gilman Veith and colleagues for application to environmental regulatory challenges. Effects-based chemical categories were built using these QSAR principles focused on the types of chemicals in the specific regulatory domain of concern, i.e. non-steroidal industrial chemicals, and based upon a mechanistic hypothesis of how these non-steroidal chemicals of seemingly dissimilar structure to 17ß-estradiol (E2) could interact with the ER via two distinct binding types. Chemicals were also tested to solubility thereby minimizing false negatives and providing confidence in determination of chemicals as inactive. The high-quality data collected in this manner were used to build an ER expert system for chemical prioritization described in a companion article in this journal.
监管机构负责解决大量化学物质的内分泌干扰潜力问题,而这些化学物质通常几乎没有或根本没有数据来做出决策。优先考虑对人类和野生动物潜在危害进行进一步筛选的最受关注的化学物质,是这一过程的初始步骤。本文介绍了使用优化的测定法来收集体外数据的情况,这些测定法旨在检测低亲和力雌激素受体(ER)结合化学物质,并使用这些数据,根据 QSAR 方法和原则,建立基于效应的化学物质类别,这些方法和原则是由 Gilman Veith 及其同事开创的,用于解决环境监管方面的挑战。基于效应的化学物质类别是根据关注的特定监管领域(即非甾体工业化学物质)中化学物质的类型,以及这些非甾体化学物质与 17β-雌二醇(E2)结构上看似不同的结构如何通过两种不同的结合类型与 ER 相互作用的机制假设来构建的。还对化学品进行了溶解度测试,从而最大限度地减少假阴性,并提高对化学品无活性的判断的信心。以这种方式收集的高质量数据被用于建立化学物质优先排序的 ER 专家系统,该系统在本杂志的另一篇文章中有描述。